Business
GMT: Net loss widened to PLN 6.0 million in H1 2024 as Genomtec advanced R&D and raised new capital
GMT: Net loss widened to PLN 6.0 million in H1 2024 as Genomtec advanced R&D and raised new capital
About this update from Genomtec Sa
Genomtec S.A. reported a net loss of PLN 6.0 million for H1 2024, with minimal sales revenue and continued reliance on equity and grants. Cash reserves increased following a major share issue, while commercialization efforts and R&D remain the company's focus.Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.